Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALKEM LABORATORIES BIOCON /
ALKEM LABORATORIES
 
P/E (TTM) x 19.7 37.5 52.5% View Chart
P/BV x 1.8 6.5 27.6% View Chart
Dividend Yield % 0.6 1.0 56.1%  

Financials

 BIOCON    ALKEM LABORATORIES
EQUITY SHARE DATA
    BIOCON
Mar-23
ALKEM LABORATORIES
Mar-23
BIOCON /
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3883,625 10.7%   
Low Rs1922,835 6.8%   
Sales per share (Unadj.) Rs93.1970.1 9.6%  
Earnings per share (Unadj.) Rs5.484.2 6.4%  
Cash flow per share (Unadj.) Rs14.6110.2 13.3%  
Dividends per share (Unadj.) Rs1.5050.00 3.0%  
Avg Dividend yield %0.51.5 33.4%  
Book value per share (Unadj.) Rs146.5756.4 19.4%  
Shares outstanding (eoy) m1,200.60119.57 1,004.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.13.3 93.5%   
Avg P/E ratio x54.138.4 141.0%  
P/CF ratio (eoy) x19.829.3 67.6%  
Price / Book Value ratio x2.04.3 46.3%  
Dividend payout %28.059.4 47.2%   
Avg Mkt Cap Rs m347,814386,207 90.1%   
No. of employees `000NANA-   
Total wages/salary Rs m21,81021,314 102.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,742115,993 96.3%  
Other income Rs m7,6812,161 355.5%   
Total revenues Rs m119,423118,153 101.1%   
Gross profit Rs m16,61115,065 110.3%  
Depreciation Rs m11,1313,104 358.6%   
Interest Rs m4,1901,074 390.3%   
Profit before tax Rs m8,97113,048 68.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5412,980 85.3%   
Profit after tax Rs m6,43010,068 63.9%  
Gross profit margin %14.913.0 114.5%  
Effective tax rate %28.322.8 124.0%   
Net profit margin %5.88.7 66.3%  
BALANCE SHEET DATA
Current assets Rs m123,34086,064 143.3%   
Current liabilities Rs m85,10737,071 229.6%   
Net working cap to sales %34.242.2 81.0%  
Current ratio x1.42.3 62.4%  
Inventory Days Days12933 395.9%  
Debtors Days Days11767 174.0%  
Net fixed assets Rs m394,07837,245 1,058.1%   
Share capital Rs m6,003239 2,510.7%   
"Free" reserves Rs m169,92690,208 188.4%   
Net worth Rs m175,92990,447 194.5%   
Long term debt Rs m152,9050-   
Total assets Rs m517,418124,541 415.5%  
Interest coverage x3.113.2 23.9%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.20.9 23.2%   
Return on assets %2.18.9 22.9%  
Return on equity %3.711.1 32.8%  
Return on capital %4.015.6 25.6%  
Exports to sales %3.114.6 21.3%   
Imports to sales %6.00-   
Exports (fob) Rs m3,46716,916 20.5%   
Imports (cif) Rs m6,654NA-   
Fx inflow Rs m3,46716,916 20.5%   
Fx outflow Rs m6,6544,190 158.8%   
Net fx Rs m-3,18712,727 -25.0%   
CASH FLOW
From Operations Rs m18,52516,825 110.1%  
From Investments Rs m-142,8181,128 -12,656.7%  
From Financial Activity Rs m130,487-17,608 -741.1%  
Net Cashflow Rs m6,411416 1,540.4%  

Share Holding

Indian Promoters % 40.4 56.7 71.1%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 24.4 86.3%  
FIIs % 6.6 8.5 77.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 43.3 91.0%  
Shareholders   434,339 65,184 666.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs ALKEM LABORATORIES Share Price Performance

Period Biocon ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 2.92% -1.18% 1.18%
1-Month -2.53% -0.99% -0.75%
1-Year 30.52% 52.26% 61.82%
3-Year CAGR -13.55% 21.70% 18.16%
5-Year CAGR -2.73% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Biocon, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.